Table 2.
The clinicopathological parameters of breast cancer patients.
| Clinicopathological parameters | Cohort 1 N (%) | Cohort 2 N (%) | |
|---|---|---|---|
| Age | ≤ 48 | 14 (56) | 20 (54.05) |
| >48 | 11 (44) | 17 (45.95) | |
| Tumor size | T1 | 6 (24) | 8 (21.62) |
| T2 | 18 (72) | 27 (72.97) | |
| T3 | — | 1 (2.7) | |
| T4 | 1 (4) | 1 (2.7) | |
| Lymph node status | N0 | 8 (32) | 14 (37.84) |
| N1 | 14 (56) | 20 (54.05) | |
| N2 | 1 (4) | 1 (2.7) | |
| N3 | 2 (8) | 2 (5.41) | |
| NACT regimen | CAX | 7 (28) | 9 (24.32) |
| CMX | 2 (8) | 2 (5.41) | |
| FAC | 13 (52) | 16 (43.24) | |
| Taxotere | 3 (12) | 8 (21.62) | |
| FAC (3) + CAX (2) | — | 1 (2.7) | |
| NACT response | Partial response | 15 (60) | 27 (72.97) |
| Stable disease | 10 (40) | 10 (27.03) | |